IceCure Medical Ltd
ICCM
$2.54
-$0.27-9.61%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -13.85% | -5.55% | -4.55% | |
| Total Depreciation and Amortization | -- | -4.82% | 2.13% | 2.79% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -48.13% | -33.22% | -27.71% | |
| Change in Net Operating Assets | -- | -67.37% | -18.30% | 189.67% | |
| Cash from Operations | -- | -30.76% | -10.30% | -0.10% | |
| Capital Expenditure | -- | 66.15% | 81.01% | 85.21% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -93.47% | -100.01% | 353.43% | |
| Cash from Investing | -- | -93.89% | -100.34% | 165.20% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 57.88% | 221.88% | 11,555.42% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | 89.33% | 205.21% | 10,968.67% | |
| Foreign Exchange rate Adjustments | -- | -36.59% | -280.00% | -256.00% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -164.48% | -191.70% | 77.38% | |